Navigation Links
Leading Health Supplement Company IQ Formulations Expands Quality Control and Assurance Department
Date:7/14/2014

Sunrise, FL (PRWEB) July 14, 2014

Top nutritional supplement provider IQ Formulations today announced the expansion of its Quality Control and Assurance Department. As the company continues its rapid growth, IQ Formulations has hired two additional, highly-qualified quality assurance (QA) and quality control (QC) officers to help ensure the superior product standards for which IQ Formulations has become known.

IQ Formulations’ newest QA and QC technicians bring decades of stellar experience and qualifications to their new positions at the leading health and supplement company. Their industry certifications and deep expertise in QA and production management, equipment design and calibration, analytical testing, product development and QA training will help sharpen the already elevated production and testing standards maintained by IQ Formulations.

At its state-of-the-art facility, which utilizes the most technologically advanced development, packaging, and laboratory equipment, IQ Formulations meticulously monitors the entire manufacturing process from start to finish. The company’s highly skilled team members screen raw materials upon receipt, evaluate all materials for conformity to specified physical and chemical properties, and perform rigorous pre-process, in-process, and post-process analyses to guarantee the superior quality of all final IQ Formulations products.

Continuing to raise the bar for the health and nutritional supplement industry, IQ Formulations intends to qualify for EU and ISO certification by 2015, utilizing its new QA and QC officers’ detailed industry expertise with these certifications and FDA Quality Systems Requirements.

“We are so thrilled to be expanding our Quality Control and Assurance Department with exceptionally credentialed technicians to even further enhance our industry-leading manufacturing and packaging processes,” said IQ Formulations CEO Jay Cohen. “At IQ Formulations, we believe in going the extra mile to ensure unbeatable quality products for our customers. Our new team members exemplify the company’s unrelenting attention to detail and commitment to excellence. We look forward to continuing to deliver elite products and services to our valued customers.”

About IQ Formulations
IQ Formulations is one of the most highly regarded and quickly growing health and nutritional supplement companies in the U.S. Founded by industry veteran Jay Cohen and headquartered in Sunrise, Florida, IQ Formulations has become an industry leader known for its uncompromising commitment to professional facilities, top-quality products with amazing results, and superior customer service. Learn more at iqformulations.com.

Read the full story at http://www.prweb.com/releases/Health-Supplements/IQ-Formulations/prweb11961524.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service
2. Biochemical cascade causes bone marrow inflammation, leading to serious blood disorders
3. Cancer Research UKs new funding scheme to nurture future world-leading scientists
4. Leading Irish scientist speaks on how the mind works to educators at ILLUSION Expo
5. Revealed:Proteins role in preventing heart muscle growth leading to heart failure
6. Developing countries face leading medical scourge of developed countries
7. NetDimensions Selected by Thales Training & Consultancy to Manage the Compliance and Learning Needs of Leading Training Organizations Across Europe
8. Leading Population Health Management Solutions Provider Offers Tips and Tricks to Maximize the Planned Visit
9. Natural Algae Astaxanthin Association Formed by Three Leading Astaxanthin Producers
10. RevitaRUGS Announces Annual Participation in AmericasMart, the Leading International Source for Consumer Goods
11. Speedskating Olympic Events Put Utah Front and Center Leading Up to the 2014 Sochi Games
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: